These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 37753954)

  • 41. Gastroenterology Practice Patterns Contribute to Missed Diagnoses of Eosinophilic Gastritis and Duodenitis.
    Chehade M; Tan J; Gehman LT
    Gastro Hep Adv; 2023; 2(3):334-342. PubMed ID: 39132645
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Eosinophilic gastrointestinal disorders in children and adolescents: A single-center experience.
    Votto M; Raffaele A; De Filippo M; Caimmi S; Brunero M; Riccipetitoni G; Marseglia GL; Licari A
    Dig Liver Dis; 2022 Feb; 54(2):214-220. PubMed ID: 34274254
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Real-World Efficacy of Dupilumab in Severe, Treatment-Refractory, and Fibrostenotic Patients With Eosinophilic Esophagitis.
    Lee CJ; Dellon ES
    Clin Gastroenterol Hepatol; 2024 Feb; 22(2):252-258. PubMed ID: 37660770
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Eosinophilic Gastrointestinal Diseases in Children: A Practical Review.
    Licari A; Votto M; D'Auria E; Castagnoli R; Caimmi SME; Marseglia GL
    Curr Pediatr Rev; 2020; 16(2):106-114. PubMed ID: 31642786
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Successful use of dupilumab for egg-induced eosinophilic gastroenteritis with duodenal ulcer: a pediatric case report and review of literature.
    Tsuge M; Shigehara K; Uda K; Kawano S; Iwamuro M; Saito Y; Yashiro M; Ikeda M; Tsukahara H
    Allergy Asthma Clin Immunol; 2023 Dec; 19(1):103. PubMed ID: 38053199
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Improvement in eosinophilic esophagitis when using dupilumab for other indications or compassionate use.
    Spergel BL; Ruffner MA; Godwin BC; Liacouras CA; Cianferoni A; Gober L; Hill DA; Brown-Whitehorn TF; Chaiboonma K; Aceves SA; Muir AM; Spergel JM
    Ann Allergy Asthma Immunol; 2022 May; 128(5):589-593. PubMed ID: 35085819
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Endoscopic Features of Eosinophilic Gastrointestinal Diseases.
    Greuter T; Katzka D
    Immunol Allergy Clin North Am; 2024 May; 44(2):357-368. PubMed ID: 38575229
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Relapse of Eosinophilic Esophagitis on Dupilumab.
    Buendia MA; Choksi YA; Hiremath G
    JPGN Rep; 2022 Nov; 3(4):e273. PubMed ID: 37168482
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Clinical Presentation of Patients with Eosinophilic Gastrointestinal Diseases beyond Eosinophilic Esophagitis.
    Papadopoulou A; Zevit N
    Immunol Allergy Clin North Am; 2024 May; 44(2):349-355. PubMed ID: 38575228
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Subtyping of Eosinophilic Esophagitis Based on Disease Presentation in a pediatric Cohort.
    Sessions J; Purington N; McGhee S; Bass D; Wang Y; Goyal A; Khavari N
    J Pediatr Gastroenterol Nutr; 2022 Oct; 75(4):e67-e74. PubMed ID: 35897130
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Recent progress in the research of Eosinophilic GastroIntestinal Diseases (EGIDs)].
    Mishiro T; Ishimura N; Ishihara S; Kinoshita Y
    Nihon Yakurigaku Zasshi; 2018; 152(4):175-180. PubMed ID: 30298838
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Disease Course and Treatment Response of Eosinophilic Gastrointestinal Diseases in Children With Liver Transplantation: Long-Term Follow-Up.
    Ozdogan E; Doganay L; Can D; Arikan C
    Am J Gastroenterol; 2021 Jan; 116(1):188-197. PubMed ID: 33065587
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Dupilumab demonstrated efficacy and was well tolerated regardless of prior use of swallowed topical corticosteroids in adolescent and adult patients with eosinophilic oesophagitis: a subgroup analysis of the phase 3 LIBERTY EoE TREET study.
    Bredenoord AJ; Dellon ES; Hirano I; Lucendo AJ; Schlag C; Sun X; Glotfelty L; Mannent L; Maloney J; Laws E; Mortensen E; Shabbir A
    Gut; 2024 Feb; 73(3):398-406. PubMed ID: 38050037
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Gene expression and clinical outcomes after dietary treatment for eosinophilic esophagitis: a prospective study.
    de Rooij WE; Diks MAP; Warners MJ; Ampting MTJV; van Esch BCAM; Bredenoord AJ
    Neurogastroenterol Motil; 2022 Oct; 34(10):e14367. PubMed ID: 35661487
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Allergic phenotype identified on allergen testing is associated with proton pump inhibitor nonresponse in eosinophilic esophagitis.
    Muftah M; Hartnett DA; Flanagan R; Redd WD; Jenkins A; Goldin AH; Hsu Blatman K; Chan WW
    J Gastroenterol Hepatol; 2024 Apr; 39(4):701-707. PubMed ID: 38185799
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Eosinophilic Gastrointestinal Diseases in Childhood.
    Koutri E; Papadopoulou A
    Ann Nutr Metab; 2018; 73 Suppl 4():18-28. PubMed ID: 30783041
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Long-Lasting Dissociation of Esophageal Eosinophilia and Symptoms After Dilation in Adults With Eosinophilic Esophagitis.
    Safroneeva E; Pan Z; King E; Martin LJ; Collins MH; Yang GY; Capocelli KE; Arva NC; Abonia JP; Atkins D; Bonis PA; Dellon ES; Falk GW; Gonsalves N; Gupta SK; Hirano I; Leung J; Menard-Katcher PA; Mukkada VA; Schoepfer AM; Spergel JM; Wershil BK; Rothenberg ME; Aceves SS; Furuta GT;
    Clin Gastroenterol Hepatol; 2022 Apr; 20(4):766-775.e4. PubMed ID: 34062314
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Baseline Peripheral Eosinophil Count Independently Predicts Proton Pump Inhibitor Response in Eosinophilic Esophagitis.
    Muftah M; Barshop K; Redd WD; Goldin AH; Lo WK; Chan WW
    J Clin Gastroenterol; 2024 Mar; 58(3):242-246. PubMed ID: 36943488
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Retrospective Comparison of Fluticasone Propionate and Oral Viscous Budesonide in Children With Eosinophilic Esophagitis.
    Fable JM; Fernandez M; Goodine S; Lerer T; Sayej WN
    J Pediatr Gastroenterol Nutr; 2018 Jan; 66(1):26-32. PubMed ID: 28489670
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Real World Experience With Dupilumab in Eosinophilic Esophagitis in Children and Young Adults at a Tertiary Care Pediatric Medical Center.
    Syverson EP; Rubinstein E
    JPGN Rep; 2022 May; 3(2):e180. PubMed ID: 37168913
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.